Body weight
Lifestyle intervention for prediabetes → Body weight
Lifestyle intervention for prediabetes → Body weight
- EvidenceScore™
- 84
- Strong
- ImpactScore™
- 75
- Positive
- ConsistencyScore™
- 83
- consistent
Last updated September 12, 2026
Key finding
Only the lifestyle group demonstrated a significant reduction in CTX after 6 months (p < 0.05).
This study investigated the metabolic effects of Metformin and lifestyle modification in early type 2 diabetes management, finding significant benefits from lifestyle changes.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Extended (5–20+ y)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study investigated the metabolic effects of Metformin and lifestyle modification in early type 2 diabetes management, finding significant benefits from lifestyle changes.
These findings emphasize the importance of lifestyle modifications in managing early type 2 diabetes, suggesting that behavioral changes can lead to significant improvements in metabolic health. This could inform treatment strategies and empower patients to take an active role in their diabetes management.
The study did not assess long-term effects beyond six months. The sample size and demographic diversity may limit generalizability. No significant changes were observed in several biochemical markers across interventions.
Published in
Publication details and source links for this paper.
Mohammed A, Shaun S, Kaiser W, et al. The metabolic effects of Metformin and lifestyle modification in early type 2 diabetes mellitus management. Aging Clinical and Experimental Research. 2026;38(1):170. doi:10.1007/s40520-026-03423-2
The lifestyle group demonstrated a significant reduction in CTX by -0.5 pg/ml (p < 0.05).
Body weight decreased significantly by -5.2 kg (p = 0.001) in the lifestyle group.
HbA1c levels decreased significantly in the lifestyle group.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Lifestyle intervention for prediabetes, Metformin and Body weight, HbA1c, Anthropometric parameters, and 4 more.
This study contributes evidence to
Primary intervention
Lifestyle intervention for prediabetes
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
4
Related topics
7
Evidence pairs
1164
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Related evidence
Evidence topic
Save evidence
Evidence topic
Save evidence
Core evidence
The primary outcomes reported in this study.
Lifestyle intervention for prediabetes → Body weight
Lifestyle intervention for prediabetes → Body weight
Metformin → Change in plasma levels of Procollagen type 1 N-terminal propeptide (P1NP)
Metformin → Change in plasma levels of Procollagen type 1 N-terminal propeptide (P1NP)
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Lifestyle intervention for prediabetes and HbA1c, Metformin Therapies and HbA1c.
This study contributes to the evidence on the following intervention-outcome relationships.
Behavioral & Lifestyle
Medications
Behavioral & Lifestyle
Curated evidence collections and hubs this study is part of.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies on Lifestyle intervention for prediabetes
Contributes to Lifestyle intervention for prediabetes evidence base.
All studies measuring Body Weight
Measures Body Weight as a key outcome.
All studies on Metformin Therapies
Contributes to Metformin Therapies evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
17 results
12 results
17 results
12 results
17 results
Generated from the study's connected evidence using Evidence Intelligence™.
Metformin Therapies appear to improve body composition.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Anthropometric parameters
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.
Lifestyle intervention for prediabetes appears to lower HbA1c.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
HbA1c
EvidenceScore™ Strong | EvidenceScore™ 87.4 | strong positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Lifestyle intervention for prediabetes may affect body weight.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Body weight
EvidenceScore™ Strong | EvidenceScore™ 84.1 | moderate positive | ConsistencyScore™ Consistent | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Metformin for change in plasma levels of procollagen type 1 n-terminal propeptide (P1NP).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Change in plasma levels of Procollagen type 1 N-terminal propeptide (P1NP)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.